Iranian Pharmaceutical Market and Industry Analysis

Due to Iran’s untapped health market and its capabilities (especially pharmaceutical market), improvement of environmental factors, recent international agreements, health transformation plan and governmental policies for supporting foreign investment serious actions have been taken by domestic and international players and investors to consider Iran’s Market. Lack of accumulation of capital, large-scale investment, the absence of big players and unfamiliarity with the new funding and management models are the key challenges regarding pharmaceutical sector development.

For this purpose, the Mana Group based on its experiences and track records in national and international aspects, has formed a team of experts in economics, finance, investment, pharmacy and medicine in order to meet the needs of domestic and foreign investors, key players of industry, policy makers and other stakeholders, and in line with the country’s development goals, to prepare the present report. In this regard, Amin Investment Bank, the country’s first investment banking institution and the founder of Center for Health Solutions as well as Nasim Salamat Pasargad Co. as the largest private holding in the health sector have sponsored this report.

It is hoped with this effort comprehensive and innovative solutions could be found to solve the existing challenges.